Kochi, 1991, The global tuberculosis situation and the new control strategy of the World Health Organization, Tubercle, 72, 1, 10.1016/0041-3879(91)90017-M
Slutkin, 1988, The effects of AIDS epidemic on the tuberculosis problem and tuberculosis programs, 21
Lombardo, 1990, Isolation of Mycobacterium tuberculosis and M. avium complex from the same skin lesions in AIDS, N Engl J Med, 323, 916, 10.1056/NEJM199009273231313
Green, 1982, Mycobacterium avium intracellulare, 97, 539
Telenti, 1993, Detection of rifampicinresistant mutations in Mycobacterium tuberculosis, Lancet, 341, 647, 10.1016/0140-6736(93)90417-F
Coker, 1992, Clinical aspects of mycobacterial infections in HIV infection, Res Microbiol, 143, 377, 10.1016/0923-2508(92)90049-T
Abrams, 1993, Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS, J Infect Dis, 167, 1459, 10.1093/infdis/167.6.1459
De Zwart, 1988, Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3 (2-pyridyl) isoquinoline derivatives. 1. Amides, J Med Chem, 31, 716, 10.1021/jm00399a005
De Zwart, 1989, Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3 (2-pyridyl) isoquinoline derivatives. 2. Amidines, J Med Chem, 32, 487, 10.1021/jm00122a033
De Zwart, 1991, Synthesis and copper-dependent antimycoplasmal activity of amides and amidines derived from 2-amino-1, 10-phenanthroline, J Med Chem, 34, 1193, 10.1021/jm00107a045
Timmerman, 1991, A new series of 2,2′-bipyridyl analogues with high activity against AIDS-complicating microorganisms, Pharm Weekbl [Sci], 13, 102
Seydel, 1994, Influence of membrane composition of various parasites on the inhibitory activity of a series of bipyridyl analogues, Chemotherapy, 40, 124, 10.1159/000239183
Cynamon, 1985, Comparative in vitro activities of MDL 473, rifampin and ansamycin against Mycobacterium intracellulare, Antimicrob Agents Chemother, 28, 440, 10.1128/AAC.28.3.440
Heifets, 1987, Determinations of MICs of conventional and experimental drugs in liquid medium by radiometric method against Mycobacterium avium complex, Drugs Exptl Clin Res, 13, 529
Heifets, 1985, Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods, Antimicrob Agents Chemother, 28, 570, 10.1128/AAC.28.4.570
Heifits, 1988, MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs, Antimicrob Agents Chemother, 32, 1131, 10.1128/AAC.32.8.1131
Tarrand, 1985, Evaluation of the Bactec radiometric method for detection of 1% resistant populations of M. tuberculosis, J Clin Microbiol, 21, 941, 10.1128/JCM.21.6.941-946.1985
Heifets, 1987, Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium avium complex, Tubercle, 68, 267, 10.1016/0041-3879(87)90067-5
Smit, 1982, Mechanisms of action of copper (I) complex of 2,9-dimethyl-1,10-phenanthroline on Mycoplasma gallispeticum, Antimicrob Agents Chemother, 21, 881, 10.1128/AAC.21.6.881
Gaisser, 1985, The influence of 2,2′-bipyridyl analogues on copper uptake of Mycoplasma gallisepticum, Europ J Med Chem, 20, 513
Raetz, 1990, Biosynthesis and function of phospholipids in Escherichia coli, J Biol Chem, 265, 1235, 10.1016/S0021-9258(19)40001-X
Minnikan D E. Lipids: complex lipids, their chemistry, biosynthesis and roles. In: Ratledge C, Standord J, eds. The biology of mycobacteria, Vol. 1. London: Academic Press: pp. 113–128.